BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Hong HJ, Chen YL. Establishment of a Gallbladder Cancer-Specific Survival Model to Predict Prognosis in Non-metastatic Gallbladder Cancer Patients After Surgical Resection. Dig Dis Sci. 2018;. [PMID: 29736837 DOI: 10.1007/s10620-018-5103-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang J, Pan Z, Zhou Q, Liu Q, Zhao F, Feng X, Lyu J. Nomogram for predicting the survival of patients with malignant melanoma: A population analysis. Oncol Lett 2019;18:3591-8. [PMID: 31516573 DOI: 10.3892/ol.2019.10720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Han D, Yang J, Xu F, Huang Q, Bai L, Wei YL, Kaaya RE, Wang S, Lyu J. Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database. Medicine (Baltimore) 2020;99:e21322. [PMID: 32756116 DOI: 10.1097/MD.0000000000021322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bennett S, Søreide K, Gholami S, Pessaux P, Teh C, Segelov E, Kennecke H, Prenen H, Myrehaug S, Callegaro D, Hallet J. Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic. Curr Oncol 2020;27:e501-11. [PMID: 33173390 DOI: 10.3747/co.27.6785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yang J, Tian G, Pan Z, Zhao F, Feng X, Liu Q, Lyu J. Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysis. Future Oncol. 2019;15:3033-3045. [PMID: 31452393 DOI: 10.2217/fon-2019-0029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 He C, Cai Z, Zhang Y, Lin X. Prognostic Model to Predict Cancer-Specific Survival for Patients With Gallbladder Carcinoma After Surgery: A Population-Based Analysis. Front Oncol 2019;9:1329. [PMID: 31921622 DOI: 10.3389/fonc.2019.01329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
6 Cai YL, Lin YX, Xiong XZ, Ye H, Li FY, Cheng NS. Postsurgical radiotherapy in stage IIIB gallbladder cancer patients with one to three lymph nodes metastases: A propensity score matching analysis. Am J Surg 2021;221:642-8. [PMID: 32859350 DOI: 10.1016/j.amjsurg.2020.08.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Shi Z, Xiao Z, Li L, Hu L, Gao Y, Zhao J, Liu Y, Huang D, Xu Q. Application of nomogram containing log odds of metastatic lymph node in gallbladder cancer patients. Ann Transl Med 2020;8:655. [PMID: 32566592 DOI: 10.21037/atm-2020-91] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Bai Y, Liu ZS, Xiong JP, Xu WY, Lin JZ, Long JY, Miao F, Huang HC, Wan XS, Zhao HT. Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol 2018; 24(45): 5167-5178 [PMID: 30568393 DOI: 10.3748/wjg.v24.i45.5167] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
9 Søreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg 2019;106:32-45. [PMID: 30582640 DOI: 10.1002/bjs.11035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
10 García P, Lamarca A, Díaz J, Carrera E, Roa JC, On Behalf Of The European-Latin American Escalon Consortium. Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients. Cancers (Basel) 2020;12:E3670. [PMID: 33297469 DOI: 10.3390/cancers12123670] [Reference Citation Analysis]
11 Okumura K, Gogna S, Gachabayov M, Felsenreich DM, McGuirk M, Rojas A, Quintero L, Seshadri R, Gu K, Dong XD. Gallbladder cancer: Historical treatment and new management options. World J Gastrointest Oncol 2021; 13(10): 1317-1335 [PMID: 34721769 DOI: 10.4251/wjgo.v13.i10.1317] [Reference Citation Analysis]
12 Cotter G, Beal EW, Poultsides GA, Idrees K, Fields RC, Weber SM, Scoggins CR, Shen P, Wolfgang C, Maithel SK, Pawlik TM. Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis. HPB 2022. [DOI: 10.1016/j.hpb.2022.06.008] [Reference Citation Analysis]
13 Zhu J, Wu Y, Xiao W, Li Y. Survival Predictors of Resectable Gallbladder Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. The American Surgeon. [DOI: 10.1177/00031348221074238] [Reference Citation Analysis]
14 Wu Y, Li Q, Cai Z, Zhang Y, Qiu Y, Yang N, Song T, Li S, Lou J, Li J, Mao X, Chen C, Zhang D, Si S, Geng Z, Tang Z. Survival prediction for gallbladder carcinoma after curative resection: Comparison of nomogram and Bayesian network models. Eur J Surg Oncol 2020;46:2106-13. [PMID: 32807616 DOI: 10.1016/j.ejso.2020.07.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Sun L, Ke X, Wang D, Yin H, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival. J Cancer 2021;12:4172-82. [PMID: 34093818 DOI: 10.7150/jca.49242] [Reference Citation Analysis]
16 Li L, Ren T, Liu K, Li ML, Geng YJ, Yang Y, Li HF, Li XC, Bao RF, Shu YJ, Weng H, Gong W, Lau WY, Wu XS, Liu YB. Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit. Front Oncol 2021;11:692647. [PMID: 34268122 DOI: 10.3389/fonc.2021.692647] [Reference Citation Analysis]
17 Chen M, Lin J, Cao J, Zhu H, Zhang B, Wu A, Cai X. Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer. Hepatobiliary Surg Nutr. 2019;8:480-489. [PMID: 31673537 DOI: 10.21037/hbsn.2019.03.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
18 Leigh N, Pletcher E, Solomon D, Sarpel U, Labow DM, Magge DR, Golas BJ. The significance of anatomic tumor location in gallbladder cancer. J Surg Oncol 2021;123:932-8. [PMID: 33368336 DOI: 10.1002/jso.26345] [Reference Citation Analysis]
19 Lin Y, Chen H, Pan F. Prognostic Nomograms to Predict Survival of Patients with Resectable Gallbladder Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Analysis. Med Sci Monit 2021;27:e929106. [PMID: 33784268 DOI: 10.12659/MSM.929106] [Reference Citation Analysis]
20 Yang C, Ren X, Cui Y, Jiang H, Yu K, Li M, Zhao X, Zhu Q, Lin S. Nomograms for predicting cancer-specific survival in patients with primary central nervous system lymphoma: a population-based analysis. Ann Transl Med 2021;9:1055. [PMID: 34422967 DOI: 10.21037/atm-21-753] [Reference Citation Analysis]
21 Li P, Song L. Prognostic Evaluation for Patients over 45 Years Old with Gallbladder Adenocarcinoma Resection: A SEER-Based Nomogram Analysis. Biomed Res Int 2020;2020:6370946. [PMID: 32733948 DOI: 10.1155/2020/6370946] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Cai YL, Lin YX, Jiang LS, Ye H, Li FY, Cheng NS. A Novel Nomogram Predicting Distant Metastasis in T1 and T2 Gallbladder Cancer: A SEER-based Study. Int J Med Sci 2020;17:1704-12. [PMID: 32714073 DOI: 10.7150/ijms.47073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]